Related Experiment Video
Updated: Mar 12, 2026
An Immature Murine Model of Reversible Unilateral Ureteral Obstruction
Published on: April 4, 2025
Pneumovesical Ureteric Reimplantation in Pediatric Patients: An Intermediate Term Result
Chin Tung Lau1, Lawrence C L Lan1, Kenneth K-Y Wong1
1Department of Surgery, The University of Hong Kong , Queen Mary Hospital, Hong Kong, China .
Insights
Pneumovesical ureteric reimplantation is a safe and effective treatment for pediatric vesicoureteric reflux (VUR) and vesicoureteric junction obstruction (VUJO). Intermediate-term results confirm its reliability and low recurrence rates.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
Background:
- Pneumovesical ureteric reimplantation is increasingly used for pediatric vesicoureteric reflux (VUR) and vesicoureteric junction obstruction (VUJO).
- This study reviews intermediate-term outcomes of this surgical technique.
Purpose of the Study:
- To evaluate the safety and efficacy of pneumovesical ureteric reimplantation in pediatric patients.
- To assess the intermediate-term outcomes, including recurrence rates and complications.
Main Methods:
- Retrospective review of pediatric patients undergoing pneumovesical ureteric reimplantation between 2005 and 2015.
- Data collected included patient demographics, operative details, and postoperative outcomes.
Main Results:
- Thirty-one patients (23 with VUR, 8 with VUJO) underwent 42 procedures.
- Mean age was 6.1 years; mean operative time was 221 minutes; mean hospital stay was 7.4 days.
- Four patients required conversion to open surgery; four had low-grade residual VUR managed conservatively. No major complications or mortality occurred.
Conclusions:
- Pneumovesical ureteric reimplantation demonstrates safety and effectiveness in pediatric VUR and VUJO.
- Intermediate-term results indicate reliability and a low recurrence rate.
- This technique shows potential to become a preferred surgical approach.
Introduction:
Pneumovesical ureteric reimplantation has gained increasing popularity for the treatment of vesicoureteric reflux (VUR) and vesicoureteric junction obstruction (VUJO) in pediatric patients. In this study we reviewed our experience at an intermediate term basis.
Methods:
A retrospective review of all patients with pneumovesical ureteric reimplantation performed in a tertiary referral center between 2005 and 2015 was carried out. Patients' demographics, operative measures, and postoperative outcomes were recorded.
Results:
Thirty-one patients were identified during the study period. Twenty-three patients had VUR and 8 patients had VUJO. A total of 42 ureteric reimplantation procedures were carried out. The mean age at operation was 6.1 years old. The mean operative time was 221 minutes. On average the length of hospital stay was 7.4 days. Four patients required conversion to open approach. Four patients had low-grade residual VUR after the operation and all of them were treated conservatively. There was no major complication or mortality.
Conclusion:
Pneumovesical ureteric reimplantation is safe and effective for pediatric patients. Intermediate term result confirmed its reliability and low recurrence rate. It has good potential to become the preferred approach of choice in the future.
Related Concept Videos
01:26Kidney Transplant II: Surgical Procedure
01:25Urinary Tract Calculi VI: Surgical Management
01:22Imaging Studies V: Intravenous Urography and Retrograde Pyelography